Method of preparing metal diboride dispersions and films
10711210 ยท 2020-07-14
Assignee
Inventors
Cpc classification
B82Y40/00
PERFORMING OPERATIONS; TRANSPORTING
C08J2327/18
CHEMISTRY; METALLURGY
B01D2257/55
PERFORMING OPERATIONS; TRANSPORTING
Y02C20/40
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
B01D2257/708
PERFORMING OPERATIONS; TRANSPORTING
C08L29/04
CHEMISTRY; METALLURGY
C08L29/04
CHEMISTRY; METALLURGY
C10L2290/542
CHEMISTRY; METALLURGY
C01P2002/80
CHEMISTRY; METALLURGY
B01D2253/116
PERFORMING OPERATIONS; TRANSPORTING
C01P2002/77
CHEMISTRY; METALLURGY
C08J2329/04
CHEMISTRY; METALLURGY
B82Y30/00
PERFORMING OPERATIONS; TRANSPORTING
Y02E50/30
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
C10L2290/547
CHEMISTRY; METALLURGY
C01P2004/24
CHEMISTRY; METALLURGY
International classification
C10L3/10
CHEMISTRY; METALLURGY
B82Y40/00
PERFORMING OPERATIONS; TRANSPORTING
B82Y30/00
PERFORMING OPERATIONS; TRANSPORTING
C08J3/215
CHEMISTRY; METALLURGY
C08L29/04
CHEMISTRY; METALLURGY
C08J3/21
CHEMISTRY; METALLURGY
Abstract
Some embodiments include a method of producing metal diboride nanomaterials having thickness down to the atomic scale and lateral areas from 10 nm to over 1 m by preparing a mixture of a metal diboride and a suspending solution. The suspending solution can be an organic solvent or a solution containing water, and optionally can include a dispersion agent, such as a surfactant, a polymer, small molecule, or biopolymer. Further, the method includes exfoliating the metal diboride by exposing the mixture to ultrasonic energy, centrifuging the mixture forming supernatant that includes a dispersion of exfoliated metal diborides, and extracting the dispersion from the supernatant. Some embodiments include extracting the supernatant and casting the solution by diluting the dispersion with a second suspending solution that includes dissolved polymer. This can result in a composite film includes a dispersion of the exfoliated metal diborides and provides improved mechanical properties.
Claims
1. A method of producing metal diboride nanomaterials comprising: preparing a mixture of at least one metal diboride and a suspending solution, the suspending solution including at least one solvent; at least partially exfoliating the at least one metal diboride by exposing the mixture to ultrasonic energy comprising ultrasonic vibrations; centrifuging the mixture and forming at least a lower phase and an adjacent supernatant, the supernatant including a dispersion of exfoliated metal diborides; and extracting at least a portion of the dispersion from the supernatant; wherein the at least one solvent is selected from N-methyl-2-pyrrolidone, dimethylformamide, cyclopentanone, cyclohexanone, N-formyl piperidine, vinyl pyrrolidone, 1,3-dimethyl-2-imidazolidinone, bromobenzene, benzonitrile, benzyl benzoate, N,N-dimethylpropylene urea, y-butrylactone, N-ethylpyrrolidone, dimethylacetamide, cyclohexylpyrrolidone, dimethyl sulfoxide, dibenzyl ether, chloroform, isopropylalcohol, cholobenzene, 1-octyl-2-pyrrolidone, 1-3 dioxolane, ethyl acetate, quinoline, benzaldehyde, ethanolamine, diethyl phthalate, NDodecyl-2-pyrrolidone, pyridine, dimethyl phthalate, formamide, ethanol, vinyl acetate, acetone, ethylene glycol, toluene, heptane, hexane, and pentane.
2. The method of claim 1, wherein the dispersion of exfoliated metal diborides includes at least one of MgB.sub.2, AlB.sub.2, TiB.sub.2, CrB.sub.2, ZrB.sub.2, NbB.sub.2, HfB.sub.2, TaB.sub.2, ScB.sub.2, VB.sub.2, MnB.sub.2, FeB.sub.2, YB.sub.2, MoB.sub.2, ReB.sub.2, UB.sub.2, WB.sub.2, and BeB.sub.2.
3. The method of claim 1, wherein the at least one solvent is water and the suspending solution is an aqueous surfactant solution including at least one of sodium cholate, sodium dodecyl sulfate, dodecylbenzene sulfonic acid sodium salt, cationic cetrimonium bromide, myristyltrimethylammonium bromide surfactant, sodium octyl sulfate, sodium tetradecyl sulfate, sodium deoxycholate, sodium taurodeoxycholate, polyoxyethylene-polyoxypropylene block copolymer, poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol), ethylenediamine tetrakis(ethoxylate-block-propoxylate) tetrol and ethylenediamine tetrakis(propoxylate-block-ethoxylate) tetrol.
4. The method of claim 1, wherein the suspending solution includes riboflavin, ssDNA, dsDNA, BSA, and a peptide or polypeptide.
Description
DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
DETAILED DESCRIPTION
(13) Before any embodiments of the invention are explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of including, comprising, or having and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless specified or limited otherwise, the terms mounted, connected, supported, and coupled and variations thereof are used broadly and encompass both direct and indirect mountings, connections, supports, and couplings. Further, connected and coupled are not restricted to physical or mechanical connections or couplings.
(14) The following discussion is presented to enable a person skilled in the art to make and use embodiments of the invention. Various modifications to the illustrated embodiments will be readily apparent to those skilled in the art, and the generic principles herein can be applied to other embodiments and applications without departing from embodiments of the invention. Thus, embodiments of the invention are not intended to be limited to embodiments shown, but are to be accorded the widest scope consistent with the principles and features disclosed herein. The following detailed description is to be read with reference to the figures, in which like elements in different figures have like reference numerals. The figures, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of embodiments of the invention. Skilled artisans will recognize the examples provided herein have many useful alternatives and fall within the scope of embodiments of the invention.
(15) Some embodiments of the invention include methods to prepare stable, high concentration dispersions of pristine atomically thin metal diboride sheets in organic solvents and aqueous solutions. Some embodiments include methods of producing solution phase dispersions of 2d metal diborides in a single step using ultrasonic acoustic cavitation. In some embodiments of the invention, stable solution phase dispersions of MgB.sub.2, AlB.sub.2, TiB.sub.2, CrB.sub.2, ZrB.sub.2, NbB.sub.2, HfB.sub.2, and TaB.sub.2 of been produced by one or more of the methods described herein. In some further embodiments of the invention, stable, high concentration dispersions of ScB.sub.2, VB.sub.2, MnB.sub.2, FeB.sub.2, YB.sub.2, MoB.sub.2, ReB.sub.2, UB.sub.2, WB.sub.2, and BeB.sub.2 can be produced by one or more of the methods as described herein.
(16) In some embodiments, pristine metal diborides can be used as starting materials. Pristine forms can be purchased from commercial vendors in powder form or as crystalline wafers. In some embodiments of the invention, the metal diborides can be used to prepare organic solvent and aqueous solvent dispersions without any additional chemical processing steps. Some embodiments include methods to disperse MB.sub.2 materials using a biocompatible dispersion agent.
(17) In some embodiments, MB.sub.2 dispersions prepared by the methods described herein can be used to form thin films of pristine MB.sub.2. In some embodiments, the MB.sub.2 dispersions prepared by the methods described herein can be applied to various articles of manufacture. In some embodiments, 2d metal diboride suspensions prepared by the methods described herein can be used for spray-on superconducting coatings, ultrahigh temperature nanocomposites, fuel cell electrodes, manufacturing equipment coatings, atmospheric reentry vehicles, in low weight/high strength armor, and as a unique class of nanomaterials to exploit for biological applications (e.g. drug delivery, antimicrobial coatings, microbial fuel cell electrodes.)
(18) In some embodiments of the invention, 2d nanosheet dispersions of MB.sub.2 can be prepared by adding about 0.4 grams of pristine metal diboride powder along with about 6 mL of solvent or aqueous surfactant solution in a 15 mL plastic centrifuge tube. In some embodiments, the mixture can be sonicated using a probe ultrasonicator (e.g., such as a Branson Digial Sonifier 450D, with a 4 mm diameter tip). Ultrasonication relies on the principle of cavitation to shear apart the sheets, which are then stabilized by the surrounding solvent or surfactant molecules. Some embodiments included sonicating 0.4 g of each bulk metal diboride powder in 6 mL of each solvent or surfactant solution at a suitable power (11-12 W) for one hour. Sonication times, amplitudes, input powers, and the sonicator tip size can be varied to change the concentration and the size (e.g. thickness, area) of the metal diborides dispersed. In some embodiments, the temperature of the mixture can be lowered during sonification using an ice water bath. The sonication can be run at higher temperatures, if necessary. Cooling with an ice water bath or a water bath is used to prevent the solvent from boiling away as power is added to the fluid during sonication.
(19) In some embodiments, the power applied to the metal diboride particles coupled with a suitable solvent/surfactant can promote separation and subsequent exfoliation of the metal diboride sheets of near atomic thickness (e.g., see
(20) In some embodiments, the centrifugation step can serve to sediment the poorly dispersed metal diboride particles and very thick flakes from the dispersion (also described herein as a lower phase). Following centrifugation to remove poorly dispersed materials, the supernatant was decanted. This process was applied to eight different metal diborides: magnesium diboride (MgB.sub.2), aluminum diboride (AlB.sub.2), titanium diboride (TiB.sub.2), chromium diboride (CrB.sub.2), zirconium diboride (ZrB.sub.2), niobium diboride (NbB.sub.2), hafnium diboride (HfB.sub.2), and tantalum diboride (TaB.sub.2). In some embodiments, the top half (also described as an upper phase) of the solution can contain monolayer to few-layer thick metal diboride nanosheets that can be harvested using a pipette and saved for further characterization. The resulting solution-phase dispersions were grey to dark black depending on the metal boridene and remained in suspension for weeks without precipitating with the exception of AlB.sub.2, which precipitates after several days. The optical absorbance spectra obtained from the dispersions are mostly featureless with the exception of MgB.sub.2 (data 270) which shows two broad peaks near 400 nm and 850 nm as shown in
(21) In some embodiments of the invention, various organic solvents can be used to disperse the MB.sub.2 materials. For example, in some embodiments, (N-methyl-2-pyrrolidone (NMP), dimethylformamide (DMF) and isopropylalcohol (IPA) can be used. In some other embodiments of the invention, aqueous solvents can be used to disperse the MB.sub.2 materials. For example, some embodiments include aqueous anionic sodium cholate (SC), sodium dodecyl sulfate (SDS), dodecylbenzene sulfonic acid sodium salt (SDBS), or cationic cetrimonium bromide (CTAB), myristyltrimethylammonium bromide (MTAB) surfactant solutions to identify those that yielded stable 2d metal diboride dispersions. The combinations of metal diboride and solvent/surfactant that were successful are summarized in Table 1 (shown marked as Y). In some embodiments, the surfactants can be used at 1% weight per volume (w/v) concentrations. Dimethylformamide (DMF) was found to be an effective solvent for MgB.sub.2 and AlB.sub.2, while N-methyl-2-pyrolidone (NMP) was effective for HfB.sub.2 and TaB.sub.2. TiB.sub.2 and CrB.sub.2 were efficiently dispersed in aqueous solution using the anionic surfactant sodium cholate (SC) and ZrB.sub.2 and NbB.sub.2 were best exfoliated in aqueous solution using the cationic surfactant myristyltrimethylammonium bromide (MTAB).
(22) In some embodiments, using the methods described earlier, MB.sub.2 compounds with metals located on the same row of the periodic table generally can be dispersible in the same solvent/surfactant combination. In some further embodiments, the 2d metal diboride sheets can be dispersed using many different solvents, including but not limited to, cyclopentanone (CPO), cyclohexanone, N-formyl piperidine (NFP), vinyl pyrrolidone (NVP), 1,3-dimethyl-2-imidazolidinone (DMEU), bromobenzene, benzonitrile, benzyl benzoate, N,N-dimethylpropylene urea (DMPU), -butrylactone (GBL), N-ethyl-pyrrolidone (NEP), dimethylacetamide (DMA), cyclohexylpyrrolidone (CHP), dimethyl sulfoxide (DMSO), dibenzyl ether, chloroform, isopropylalcohol (IPA), cholobenzene, 1-octyl-2-pyrrolidone (N8P), 1-3 dioxolane, ethyl acetate, quinoline, benzaldehyde, ethanolamine, diethyl phthalate, N-Dodecyl-2-pyrrolidone (N12P), pyridine, dimethyl phthalate, formamide, ethanol, vinyl acetate, acetone, ethylene glycol, toluene, heptane, hexane, and pentane. Similarly, many different anionic, non-ionic, and cationic surfactants can be used, including but not limited to, sodium decyl sulfate, sodium octyl sulfate, sodium tetradecyl sulfate, sodium deoxycholate, sodium taurodeoxycholate, Pluronic F-68, Pluronic P-123, Tetronic 904, and Tetronic 1107. Pluronic and Tetronic are registered trademarks of BASF Corporation, Parsippany, N.J.
(23) TABLE-US-00001 TABLE 1 Matrix showing successful metal diboride and solvent/surfactant dispersion pairs Valence Metal diboride electrons CTAB MTAB SC SDS SDBS DMF NMP IPA MgB.sub.2 3s.sup.2 N N Y N AlB.sub.2 3s.sup.2 3p.sup.1 N N Y N TiB.sub.2 3d.sup.2 4s.sup.2 N Y Y Y N Y CrB.sub.2 3d.sup.5 4s.sup.1 Y Y Y Y N Y ZrB.sub.2 4d.sup.2 5s.sup.2 Y Y N N Y NbB.sub.2 4d.sup.4 5s.sup.1 N Y Y* N N HfB.sub.2 4f.sup.14 5d.sup.2 N N N Y Y TaB.sub.2 6s.sup.2 N N N Y
(24) Referring to the contents of Table 1, Y marks combinations that produced successful stable dispersions, N marks unsuccessful combinations, Y* marks a combination that required 9 hours of sonication for successful dispersion, and blank cells are those combinations that were not tested.
(25) TEM images of the 2d metal diboride nanosheets revealed monolayer to few layer nanomaterials (e.g., see
(26) AFM analysis was performed on nanosheets of HfB.sub.2 prepared by the methods described herein and deposited onto a SiO.sub.2/Si substrate.
(27) Electron energy loss spectroscopy (EELS) was used to identify the elemental makeup of the metal boridenes. For example,
(28) The concentrations of the metal boridene liquid-phase dispersions were determined using ICP-MS. These measurements showed a broad range of concentrations from a high concentration of 2.4 mg/mL for MgB.sub.2 to a low concentration of 0.07 mg/mL for ZrB.sub.2 (graph 400 of
(29) To determine the extinction coefficient of MgB.sub.2 and its loading in dispersions, 8.25 g of MgB.sub.2 was dispersed in 110 ml of DMF in a 500 ml steel beaker by sonicating at 50% power (49 W) for 2 hours using a 13 mm diameter titanium tip. The top 100 ml of the resulting dispersion was equally divided into four 50 ml centrifuge tubes, and then centrifuged at 4200 rpm for 40 minutes at room temperature using a S-4-72 rotor. The top 18 mL of the dispersion was collected from each tube and the absorbance spectrum was obtained. About 70 mL of the resulting dispersion was flocculated by adding excess methanol and the newly aggregated MgB.sub.2 was left to settle for several hours. The flocculated particles were then filtered through a PTFE membrane (pore size 100 nm) and thoroughly rinsed with methanol. The weight of the filter paper before and after filtration was measured to determine the mass of MgB.sub.2 in the original 70 mL dispersion. From this procedure, the extinction coefficient of MgB.sub.2 at 651 nm was calculated to be 4.002 mL mg.sup.1 cm.sup.1. The concentration of the MgB.sub.2/DMF dispersion was also found to be 0.26 mg mL.sup.1, a reasonably high concentration for a solution-phase two-dimensional nanomaterial preparation.
(30) The high surface area and biocompatibility of the two-dimensional metal diborides could enable them to circulate in the body and deliver drugs to cells. The biocompatibility of metal diborides prepared by the methods described herein was examined by measuring the cytotoxicity of ZrB.sub.2/BSA dispersions in HeLa cell cultures using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. A starting ZrB.sub.2/BSA suspension was added to a maximum concentration of 50 g mL.sup.1 and at progressively lower concentrations to cultures over a period of 24 hours. The addition of ZrB.sub.2 had no effect on cell viability. The use of nucleic acids as a means of producing stable suspensions of the metal diborides was examined. Metal diborides were dispersed with dsDNA by taking 200 mg of metal diboride powder and mixing it with 5 mL of dsDNA solution (0.4 mg/ml). This mixture was sonicated for 2 hours at 12 W power using a 4 mm diameter tip. The resulting dispersion was centrifuged at 5000 g for 5 minutes and the supernatant harvested for characterization. This procedure was used for six metal diborides (ZrB.sub.2, HfB.sub.2, NbB.sub.2, CrB.sub.2, TaB.sub.2, TiB.sub.2) and found that all six yielded stable dispersions with dsDNA. We investigated the ability of dsDNA-dispersed CrB.sub.2 and ZrB.sub.2 to adsorb the common chemotherapy drug doxorubicin (DOX). 0.1 mL of the dsDNA metal diboride sample was mixed with various concentrations of DOX (typically 10 to 50 g mL-1) in water. This mixture was then shaken at 800 rpm and 37 C. for 24 hours (the shaking speed, temperature, and duration of this reaction can be varied). After nanomaterial/DOX loading, the sample was centrifuged at 21,000 g for 5 minutes to pellet the DOX/metal diboride conjugate. After removal of the supernatant, the pellet was re-suspended in water. This centrifugation and re-suspension procedure was repeated multiple times to remove excess DOX from the solution. Finally, the sample was dispersed in water and sonicated in a bath for two to three minutes to re-disperse any aggregates that had formed during the procedure. Optical absorbance spectroscopy was used to characterize the resulting DOX-loaded metal diboride samples. Control absorbance spectra were taken of the dsDNA/metal diboride and the DOX alone and were used to determine the concentrations of both in the drug-loaded samples. This analysis indicated that CrB.sub.2/dsDNA was capable of loading up to 39 g mL.sup.1, while ZrB2/dsDNA could load up to 35 g mL.sup.1.
(31) ssDNA was examined as a dispersion agent for ZrB.sub.2. In these experiments, 200 mg of ZrB.sub.2 powder was mixed with 5 ml of ssDNA solution (0.2 mg mL.sup.1) and the sample was sonicated for 2 hours at 20 W power using a 4 mm diameter tip. The solution was centrifuged at 5000 g for 5 minutes and the supernatant decanted for optical studies. The results showed that the amount of ZrB.sub.2 that could be dispersed using ssDNA depended strongly on the sequence of DNA used. ssDNA with 20 consecutive adenine bases (A20) and 20 consecutive cytosines (C20) yielded the lowest dispersion efficiencies; while T20 (20 thymines) and (GGGGT)4, where G is guanine, provided the highest concentrations for the single (or nearly single) nucleotide ssDNAs. Using (GT)10 and (GT)20, which have identical base compositions but different lengths, showed that the 40-nt ssDNA dispersed 50% more ZrB.sub.2 than the 20-nt ssDNA.
(32) Metal diborides functionalized with dsDNA can be used to deliver dsDNA into the cells for use with DNA vaccines and for DNA transfection. Metal diborides functionalized with ssDNA have uses for biological imaging (for instance if ssDNA is conjugated to a fluorophore) and can be used to deliver ssDNA into the cell, for example for gene knockdown via a delivered antisense oligonucleotide. The results using DNA as a dispersion agent suggests that ssRNA and dsRNA will also likely be compatible. Metal diboride/RNA conjugates could be employed for siRNA delivery and for RNA vaccines. Furthermore, ssDNA and ssRNA can be used as nanoscale glues to bind metal diborides to other nucleic-acid-functionalized nanomaterials, such as DNA origami, carbon nanotubes, gold nanoparticles, and other metal diborides. A variety of chemically modified nucleic acids can also be used as dispersion agents for the metal diborides.
(33) Some further embodiments include the use of riboflavin for metal diboride dispersion. The metal diboride ZrB.sub.2 was dispersed the fluorescent, low molecular weight biomolecule riboflavin. 400 mg of ZrB.sub.2 was mixed with 5 mL riboflavin aqueous solution (5 mg mL.sup.1), and the sample was sonicated for 2 hours at 12 W power using a 4 mm diameter tip. The solution was centrifuged at 5000 g for 5 minutes and the supernatant decanted. An initial yellow/orange riboflavin solution gained a much darker color upon dispersion of the ZrB.sub.2. Following removal of the excess riboflavin from the dispersion, the ZrB.sub.2/riboflavin was exposed to UV light and fluorescence was measured. ZrB.sub.2/riboflavin conjugates prepared using the above methods retained the green fluorescence of the riboflavin, demonstrating that the ZrB.sub.2 does not strongly quench the fluorescence of adsorbed molecules, which supports bioimaging applications for metal diboride dispersions.
(34) Some embodiments include the integration of the exfoliated 2D nanoflakes into macroscopic polymer composites. For example, solution-phase dispersion of metal diborides enables facile incorporation of these two-dimensional materials into composite materials with tunable properties. These composite materials can take advantage of the enhanced thermal stability, chemical stability, and hardness of the metal diborides to improve their properties. Some embodiments include a polymer composite containing CrB.sub.2 as a filler material. For example, 400 mg of CrB.sub.2 was dispersed in 6 mL of 10% solution of Nafion D-520 in water (the overall Nafion concentration being 0.5%) by sonicating at 20% power (14 W) for 1 hour using a 4 mm diameter tip. The resulting dispersion was centrifuged at 5000 g for 4 minutes to remove the larger particles. 3 mL of the above dispersion was mixed with 5 mL of Nafion D-520 and then poured into a dish and dried overnight in an oven at 60 C. The resulting film was flexible and semitransparent.
(35) Some further embodiments include the dispersion of metal boridenes in 1% aqueous polyvinyl alcohol (PVA) solution via ultrasonication to yield CrB.sub.2 suspensions with the high concentrations and stability. For example, to synthesize composites with PVA, 1.3 g of chromium diboride was sonicated in 20 mL of 1% aqueous PVA solution for 1 hour at 30% amplitude and the resulting suspension was distributed equally in 1.5 mL tubes and centrifuged at 5000 rcf for 5 minutes. The above dispersion was mixed with 5% aqueous PVA by vortexing to obtain the required concentrations and then it was bath sonicated for 20 minutes. Then 24 mL of the above dispersion was poured in a petri dish and dried in an oven at 60 C. for 48 hours. The resulting membranes were peeled from the petri dishes, cut into rectangular pieces (3 cm1 cm) and their thicknesses were measured. Then these were tested mechanically using a tensile tester at a strain rate of 0.05 mm/s. At least three strips were measured for each concentration. The ratio of CrB.sub.2PVA dispersion and the pure PVA solution was varied to obtain composites with different mass fractions of CrB.sub.2 and the mechanical strength was of multiple polymer membranes was measured. The polymer composites remained quite flexible with the addition of CrB.sub.2 at 4% and 8% mass loadings. For example, see graph 500 of
(36) TABLE-US-00002 PVA Only 4% CrB.sub.2 in PVA 8% CrB.sub.2 in PVA UTS (MPa) 50 +/ 8 93 +/ 17 83 +/ 13 E (GPa) 0.7 +/ 0.1 1.1 +/ 0.5 1.1 +/ 0.3 Strain at UTS (%) 10 +/ 1 10 +/ 2 10 +/ 2
(37) Table 2 showing the ultimate tensile strength (UTS), elastic modulus, and the strain at UTS of the CrB.sub.2-PVA and PVA-only polymer membranes.
(38) In reference to
(39) Scanning tunneling microscope (STM) analysis was performed on nanosheets of ZrB.sub.2 prepared in the solvent IPA by the methods described herein and deposited onto a highly ordered pyrolytic graphite (HOPG) substrate using spin-coating.
(40) It will be appreciated by those skilled in the art that while the invention has been described above in connection with particular embodiments and examples, the invention is not necessarily so limited, and that numerous other embodiments, examples, uses, modifications and departures from the embodiments, examples and uses are intended to be encompassed by the claims attached hereto. The entire disclosure of each patent and publication cited herein is incorporated by reference, as if each such patent or publication were individually incorporated by reference herein. Various features and advantages of the invention are set forth in the following claims.